Risk Factors of Haemorrhagic Transformation for Acute Ischaemic Stroke in Chinese Patients Receiving Intravenous Recombinant Tissue Plasminogen Activator: A Systematic Review and Meta-analysis
HE Li. Risk Factors of Haemorrhagic Transformation for Acute Ischaemic Stroke in Chinese Patients Receiving Intravenous Recombinant Tissue Plasminogen Activator: A Systematic Review and Meta-analysis[J]. Chinese Journal of Stroke, 2018, 13(11): 1202-1204.
[1] LIU L，WANG D，WONG K S，et al. Stroke andstroke care in China：Huge burden，significantworkload，and a national priority[J]. Stroke，2011，42（12）：3651-3654.[2] LIU M，PAN Y，ZHOU L，et al. Predictors of postthrombolysissymptomatic intracranial hemorrhagein Chinese patients with acute ischemic stroke[J/OL].PloS One，2017，12（9）：e0184646. https：//dx.doi.org/10.1371/journal.pone.0184646.[3] CUCCHIARA B，TANNE D，LEVINE S R，et al.A risk score to predict intracranial hemorrhage afterrecombinant tissue plasminogen activator for acuteischemic stroke[J]. J Stroke Cerebrovasc Dis，2008，17（6）：331-333.[4] LOU M，SAFDAR A，MEHDIRATTA M，et al. TheHAT Score：a simple grading scale for predictinghemorrhage after thrombolysis[J]. Neurology，2008，71（18）：1417-1423.[5] STRBIAN D，ENGELTER S，MICHEL P，et al.Symptomatic intracranial hemorrhage after strokethrombolysis：the SEDAN score[J]. Ann Neurol，2012，71（5）：634-641.[6] MENON B K，SAVER J L，PRABHAKARAN S，etal. Risk score for intracranial hemorrhage in patientswith acute ischemic stroke treated with intravenoustissue-type plasminogen activator[J]. Stroke，2012，43（9）：2293-2299.[7] MAZYA M，EGIDO J A，FORD G A，et al.Predicting the risk of symptomatic intracerebralhemorrhage in ischemic stroke treated withintravenous alteplase：safe Implementationof Treatments in Stroke（SITS）symptomaticintracerebral hemorrhage risk score[J]. Stroke，2012，43（6）：1524-1531.[8] SAPOSNIK G，GUZIK A K，REEVES M，et al. Stroke Prognostication using Age and NIH StrokeScale：SPAN-100[J]. Neurology，2013，80（1）：21-28.[9] NG K W，SHARMA V K. Low-dose versusstandard-dose tissue plasminogen activator forintravenous thrombolysis in Asian acute ischemicstroke patients[J/OL]. Stroke，2010，41（8）：e547-548. https：//www.ahajournals.org/doi/abs/10.1161/STROKEAHA.110.582403.[10] WONG L K. Global burden of intracranialatherosclerosis[J]. Int J Stroke，2006，1（3）：158-159.[11] C S ANDERSON，M WOODWARD，JCHALMERS，et al. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute IschemicStroke[J]. N Engl J Med，2016，374（24）：2313-2323.[12] WARDLAW J M，KOUMELLIS P，LIUM. Thrombolysis（different doses，routes ofadministration and agents）for acute ischaemicstroke[J/OL]. Cochrane Database Syst Rev，2013，（5）：CD000514. https：//www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000514.pub3.
